TipRanks
Go Ultimate55% OFF

NervGen Pharma (9UA) Cash flow

NervGen Pharma Cash Flow

DE:9UA's free cash flow for Q2 2026 was $-5.81M. For the 2026 fiscal year, DE:9UA's free cash flow was increased by $0.00 and operating cash flow was $-5.81M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowMar 26Mar 25Mar 24Dec 22Dec 21
$ -19.50M$ -16.83M$ -11.30M$ -17.63M$ -8.33M
$ 100.93K$ 58.83K$ -138.87K$ -20.92K$ -45.43K
$ 23.76M$ 22.68M$ 766.35K$ 22.44M$ 19.76M
$ 22.07M$ 17.26M$ 11.66M$ 22.25M$ 17.06M
$ -19.50M$ -16.83M$ -11.30M$ -17.65M$ -8.33M

Currency in CAD

NervGen Pharma Cash Flow

-30M-20M-10M010M20M30M201720182019202020212022202320242025OperatingInvestingFinancing